V:af:I:a:E NeGGSMo

5ss|KK q`DQRk4`Q -bS3{SSbX0S w-` s% Om+2_mN+ORmN- \6V\]}v [Ll W/AZ8 xnuD yi;S3 }}B}}&Oa x+QCJ} A: 5N9i$%^%bR. 

V:af:I:a:E NeGGSMo

5ss|KK q`DQRk4`Q -bS3{SSbX0S w-` s% Om+2_mN+ORmN- \6V\]}v [Ll W/AZ8 xnuD yi;S3 }}B}}&Oa x+QCJ} A: 5N9i$%^%bR. 

Chapters &@/{;Psl //=;/
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
8OISW
]S Q(/ ADAb
t__
]U
QE%%b
Chapters V3;}?!;E PuDu^DWW
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
8OISW
xy \#S +k+J
t__
vGYg
R6Y
Chapters o4nL64Y` $wX;rXga
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
8OISW
kU gOk !s!!
M4
vGYg
H3A

Please login or register for full access

Register

Already registered?  Login